Solesence Inc(SLSN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.03 | Insider Own | 74.05% | Shs Outstand | 70.7M | Perf Week | -9.56% |
| Market Cap | 0.06B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 18.3M | Perf Month | -2.16% |
| Enterprise Value | 0.08B | PEG | - | EPS next Q | - | Inst Own | 4.48% | Short Float | 2.01% | Perf Quarter | -12.06% |
| Income | -0.00B | P/S | 1.04 | EPS this Y | - | Inst Trans | -12.45% | Short Ratio | 14.8 | Perf Half Y | -40.58% |
| Sales | 0.06B | P/B | 4.37 | EPS next 5Y | - | ROA | -3.54% | Short Interest | 0.37M | Perf YTD | -48.97% |
| Book/sh | 0.19 | P/C | 54.77 | EPS past 3/5Y | - -0.94% | ROE | -12% | 52W High | -78.58% ($3.80) | Perf Year | -77.26% |
| Cash/sh | 0.01 | P/FCF | - | Sales past 3/5Y | 18.48% 29.38% | ROIC | -9.3% | 52W Low | 32.72% ($0.61) | Perf 3Y | -10.55% |
| Dividend Est. | - | EV/EBITDA | 76.11 | EPS Y/Y TTM | -135.74% | Gross Margin | 26.88% | Volatility(W/M) | 5.55% 9.8% | Perf 5Y | -73.66% |
| Dividend TTM | - | EV/Sales | 1.43 | Sales Y/Y TTM | -14.05% | Oper. Margin | -0.07% | ATR (14) | 0.08 | Perf 10Y | 31.29% |
| Dividend Ex-Date | - | Quick Ratio | 0.47 | EPS Q/Q | -105.98% | Profit Margin | -3.4% | RSI (14) | 43.64 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.97 | Sales Q/Q | -24.69% | SMA20 | -6.34% ($0.86) | Beta | 1.34 | Target Price | - |
| Payout | - | Debt/Eq | 1.73 | Earnings | 2026/8/19 | SMA50 | -6.4% ($0.87) | Rel Volume | 0.93 | Prev Close | $0.77 |
| Employees | 115 | LT Debt/Eq | 0.54 | EPS/Sales Surpr. | - | SMA200 | -24.84% ($1.08) | Avg Volume(3M) | 0.02M | Price | $0.81 |
| IPO | 1997/11/26 | Option/Short | No/Yes | Trades | 156 | Volume | 23,018 | Change | 5.69% |
🧴 A skin health science company leading innovation in the global beauty market through its proprietary mineral-based skincare technology. Leveraging Kleair™, a transparent Zinc Oxide technology with no white cast, the company delivers high-performance sunscreen and cosmetic solutions.
Over the past 1 year, on the lower side
79% below its 1-year high.
Traded about as much as usual. That is 93% of its average volume.
SLSN has weak earnings and a weak balance sheet
Of every $100 in sales, $0.07 is lost.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $104. Peers typically go for $147. Compared with its own 3-year average, it is 67% pricier now.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -73.7%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 4.5%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #23 of 30 in the industry
Based on market cap of $58M.
FAQ
What kind of company is SLSN?
SLSN belongs to the Consumer Defensive sector and operates in the Household & Personal Products industry.
What is the market cap of SLSN?
The market cap of SLSN is approximately $58M, ranking 4,767 within its sector.
What is the 52-week high and low for SLSN?
SLSN has recorded a 52-week high of $3.80 and a low of $0.61.
